Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | EW Edwards Lifesciences | ABT Abbott Laboratories |
|---|---|---|
| Price | $88.26 +0.0% | $102.61 +0.4% |
| StockIQ Score | 57C Moderate Risk: Medium | 51C- Moderate Risk: Medium |
| Technical | 39F | 19F |
| Fundamental | 78B+ | 72B |
| Growth | 51C- | 45D+ |
| Fair Value | 33F | 38F |
| News | 100A+ | 100A+ |
| Quality | 63C+ | 63C+ |
| Risk | 54C- | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Edwards Lifesciences (EW) outperforms Abbott Laboratories (ABT) in fundamental strength with a score of 78 versus 72. However, ABT has a slightly higher technical score (50 vs. 43) and better valuation (38 vs. 33). Both share the same moderate rating, but EW shows stronger long-term stability, while ABT edges out in short-term price trends and affordability.